D
Lineage Cell Therapeutics, Inc. LCTX
$1.27 $0.0958.12% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 10.91M 9.56M 9.50M 8.72M 6.19M
Total Other Revenue -- -- -- -- --
Total Revenue 10.91M 9.56M 9.50M 8.72M 6.19M
Cost of Revenue 12.91M 12.68M 12.66M 13.25M 13.95M
Gross Profit -2.00M -3.12M -3.16M -4.53M -7.76M
SG&A Expenses 18.23M 18.03M 18.17M 14.53M 14.16M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 31.31M 30.88M 30.98M 27.92M 28.25M
Operating Income -20.40M -21.32M -21.48M -19.20M -22.07M
Income Before Tax -40.76M -16.17M -18.58M -20.05M -24.20M
Income Tax Expenses -- -- -- 0.00 0.00
Earnings from Continuing Operations -40.76 -16.17 -18.58 -20.05 -24.20
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -152.00K -39.00K -27.00K -65.00K 16.00K
Net Income -40.91M -16.21M -18.61M -20.11M -24.19M
EBIT -20.40M -21.32M -21.48M -19.20M -22.07M
EBITDA -19.77M -20.72M -20.87M -18.57M -21.40M
EPS Basic -0.18 -0.08 -0.10 -0.11 -0.13
Normalized Basic EPS -0.07 -0.05 -0.06 -0.06 -0.07
EPS Diluted -0.18 -0.08 -0.10 -0.11 -0.13
Normalized Diluted EPS -0.07 -0.05 -0.06 -0.06 -0.07
Average Basic Shares Outstanding 883.44M 843.89M 800.75M 735.57M 721.60M
Average Diluted Shares Outstanding 883.44M 843.89M 800.75M 735.57M 721.60M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --